131 related articles for article (PubMed ID: 29464899)
1. Proteomic Adaptation of Australian Epidemic Bordetella pertussis.
Luu LDW; Octavia S; Zhong L; Raftery MJ; Sintchenko V; Lan R
Proteomics; 2018 Apr; 18(8):e1700237. PubMed ID: 29464899
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Whole Cell Proteome and Secretome of Epidemic
Luu LDW; Octavia S; Zhong L; Raftery MJ; Sintchenko V; Lan R
Front Microbiol; 2018; 9():2851. PubMed ID: 30538686
[TBL] [Abstract][Full Text] [Related]
3. Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens.
Luu LDW; Octavia S; Aitken C; Zhong L; Raftery MJ; Sintchenko V; Lan R
Vaccine; 2020 Jan; 38(3):539-548. PubMed ID: 31703933
[TBL] [Abstract][Full Text] [Related]
4. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.
Octavia S; Sintchenko V; Gilbert GL; Lawrence A; Keil AD; Hogg G; Lan R
J Infect Dis; 2012 Apr; 205(8):1220-4. PubMed ID: 22416243
[TBL] [Abstract][Full Text] [Related]
5. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
6. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
8. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
[TBL] [Abstract][Full Text] [Related]
9. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
Bailon H; León-Janampa N; Padilla C; Hozbor D
BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
[TBL] [Abstract][Full Text] [Related]
10. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
11. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
[TBL] [Abstract][Full Text] [Related]
12. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of Bordetella pertussis reveals requirement of RNA chaperone Hfq for Type III secretion system functionality.
Bibova I; Hot D; Keidel K; Amman F; Slupek S; Cerny O; Gross R; Vecerek B
RNA Biol; 2015; 12(2):175-85. PubMed ID: 25674816
[TBL] [Abstract][Full Text] [Related]
14. Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study.
Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
Vaccine; 2016 Jul; 34(34):3967-71. PubMed ID: 27346304
[TBL] [Abstract][Full Text] [Related]
15. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
17. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
[TBL] [Abstract][Full Text] [Related]
18. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
19. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis.
Clarke M; McIntyre PB; Blyth CC; Wood N; Octavia S; Sintchenko V; Giles L; Quinn H; Hill V; Hanly G; Lan R; Marshall HS
J Infect; 2016 Feb; 72(2):171-8. PubMed ID: 26675318
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
Byrne S; Slack AT
BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
